Treace Medical Concepts (TMCI) Stock Statistics & Valuation Metrics

Treace Medical Concepts has a market cap or net worth of $277.70M. The enterprise value is $286.33M.

Market Cap

$277.70M

Enterprise Value

$286.33M

Treace Medical Concepts has 65,034,550 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

65,034,550

Owned by Insiders

27.79%

Owned by Institutions

11.15%

Treace Medical Concepts’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -33.86%.

Return on Equity (ROE)

-0.68

Return on Assets (ROA)

-0.31

Return on Invested Capital (ROIC)

-33.86%

Return on Capital Employed (ROCE)

-0.34

Revenue Per Employee

472.64K

Profits Per Employee

-131.12K

Employee Count

450

Asset Turnover

1.12

Inventory Turnover

1.19

The current PE Ratio of Treace Medical Concepts is -4.60. Treace Medical Concepts’s PEG ratio is 0.26.

PE Ratio

-4.60

PS Ratio

1.36

PB Ratio

4.11

Price to FCF

-11.11

Price to Operating Cash Flow

-19.09

PEG Ratio

0.26

In the last 12 months, Treace Medical Concepts had revenue of 212.69M and earned -59.00M in profits. Earnings per share was -0.93.

Revenue

212.69M

Gross Profit

169.75M

Operating Income

-54.15M

Pretax Income

-59.00M

Net Income

-59.00M

EBITDA

-43.18M

Earnings Per Share (EPS)

-0.93

In the last 12 months, operating cash flow was -14.58M and capital expenditures -10.47M, giving a free cash flow of -25.05M billion.

Operating Cash Flow

-14.58M

Free Cash Flow

-25.05M

Free Cash Flow per Share

-0.39

Treace Medical Concepts pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-9.00%

Earnings Yield

-21.38%

Beta

2.50

52-Week Price Change

-35.05%

50-Day Moving Average

4.43

200-Day Moving Average

3.24

Relative Strength Index (RSI)

48.01

Average Volume (3m)

280.89K

Treace Medical Concepts upcoming earnings date is Nov 06, 2026, Before Open (Not Confirmed).

Last Earnings Date

Aug 07, 2026

Next Earnings Date

Nov 06, 2026

Ex-Dividend Date

―

Treace Medical Concepts as a current ratio of 4.31, with Debt / Equity ratio of 16.01%

Current Ratio

4.31

Quick Ratio

3.13

Debt to Market Cap

0.09

Net Debt to EBITDA

-0.08

Interest Coverage Ratio

-10.18

In the past 12 months, Treace Medical Concepts has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

Treace Medical Concepts EV to EBITDA ratio is -7.48, with an EV/FCF ratio of -13.51.

EV to Sales

1.65

EV to EBITDA

-7.48

EV to Free Cash Flow

-13.51

EV to Operating Cash Flow

-23.21

Treace Medical Concepts has $45.62M in cash and marketable securities with $72.69M in debt, giving a net cash position of -$27.07M billion.

Cash & Marketable Securities

$45.62M

Total Debt

$72.69M

Net Cash

-$27.07M

Net Cash Per Share

-$0.42

Tangible Book Value Per Share

$0.74

Gross margin is 79.45%, with operating margin of -26.17%, and net profit margin of -28.99%.

Gross Margin

79.45%

Operating Margin

-26.17%

Pretax Margin

-28.99%

Net Profit Margin

-28.99%

EBITDA Margin

-22.04%

EBIT Margin

-26.15%

The average price target for Treace Medical Concepts is $5.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$5.50

Price Target Upside

28.50% Upside

Analyst Consensus

Moderate Buy

Analyst Count

3

Revenue Growth Forecast

-3.95%

EPS Growth Forecast

-17.90%

Smart Score

6

AI Score

52